| Regulation of immune responses by the airway epithelial cell landscape RJ Hewitt, CM Lloyd Nature Reviews Immunology 21 (6), 347-362, 2021 | 272 | 2021 |
| The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma R Hewitt, H Farne, A Ritchie, E Luke, SL Johnston, P Mallia Therapeutic advances in respiratory disease 10 (2), 158-174, 2016 | 191 | 2016 |
| Dynamics of human monocytes and airway macrophages during healthy aging and after transplant AJ Byrne, JE Powell, BJ O’Sullivan, PP Ogger, A Hoffland, J Cook, ... Journal of Experimental Medicine 217 (3), e20191236, 2020 | 117 | 2020 |
| Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease B Vijayakumar, K Boustani, PP Ogger, A Papadaki, J Tonkin, CM Orton, ... Immunity 55 (3), 542-556. e5, 2022 | 109 | 2022 |
| The transferrin receptor CD71 delineates functionally distinct airway macrophage subsets during idiopathic pulmonary fibrosis SJ Allden, PP Ogger, P Ghai, P McErlean, R Hewitt, R Toshner, ... American journal of respiratory and critical care medicine 200 (2), 209-219, 2019 | 91 | 2019 |
| Itaconate controls the severity of pulmonary fibrosis PP Ogger, GJ Albers, RJ Hewitt, BJ O’Sullivan, JE Powell, E Calamita, ... Science immunology 5 (52), eabc1884, 2020 | 89 | 2020 |
| The respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis R Invernizzi, BG Wu, J Barnett, P Ghai, S Kingston, RJ Hewitt, J Feary, ... American Journal of Respiratory and Critical Care Medicine 203 (3), 339-347, 2021 | 54 | 2021 |
| The respiratory microbiome in idiopathic pulmonary fibrosis RJ Hewitt, PL Molyneaux Annals of translational medicine 5 (12), 2017 | 45 | 2017 |
| Primary nodal anthracosis identified by EBUS-TBNA as a cause of FDG PET/CT positive mediastinal lymphadenopathy RJ Hewitt, C Wright, D Adeboyeku, D Ornadel, M Berry, ... Respiratory medicine case reports 10, 48-52, 2013 | 34 | 2013 |
| Idiopathic pulmonary fibrosis: new and emerging treatment options RJ Hewitt, TM Maher Drugs & Aging 36, 485-492, 2019 | 27 | 2019 |
| DNA methylome alterations are associated with airway macrophage differentiation and phenotype during lung fibrosis P McErlean, CG Bell, RJ Hewitt, Z Busharat, PP Ogger, P Ghai, GJ Albers, ... American Journal of Respiratory and Critical Care Medicine 204 (8), 954-966, 2021 | 20 | 2021 |
| Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1 H Stölting, L Baillon, R Frise, K Bonner, RJ Hewitt, PL Molyneaux, ... Mucosal immunology 15 (5), 952-963, 2022 | 16 | 2022 |
| Screening tests for tuberculosis before starting biological therapy RJ Hewitt, M Francis, A Singanayagam, OM Kon Bmj 350, 2015 | 16 | 2015 |
| Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease RJ Hewitt, EC Bartlett, R Ganatra, H Butt, V Kouranos, F Chua, M Kokosi, ... Thorax 77 (11), 1149-1151, 2022 | 15 | 2022 |
| Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles S Asghar, S Monkley, DJF Smith, RJ Hewitt, K Grime, LA Murray, ... Respiratory Research 24 (1), 51, 2023 | 10 | 2023 |
| The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. 2016; 10 (2): 158–74 R Hewitt, H Farne, A Ritchie, E Luke, SL Johnston, P Mallia Thorax 69 (3), 247-53, 2014 | 10 | 2014 |
| P276 Development of patient reported experience measure (PREM) for idiopathic pulmonary fibrosis (IPF) W ACCELEROMETERS Thorax 71 (3), A1-A288, 2016 | 7 | 2016 |
| Development and evaluation of a pocket card to support prescribing by junior doctors in an English hospital M Reynolds, E Larsson, R Hewitt, S Garfield, BD Franklin International journal of clinical pharmacy 37, 762-766, 2015 | 5 | 2015 |
| Lung extracellular matrix modulates KRT5+ basal cell activity in pulmonary fibrosis RJ Hewitt, F Puttur, DCA Gaboriau, F Fercoq, M Fresquet, WJ Traves, ... Nature Communications 14 (1), 6039, 2023 | 4 | 2023 |
| Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease K Boustani, P Ghai, R Invernizzi, RJ Hewitt, TM Maher, QZ Li, ... ERJ Open Research 8 (1), 2022 | 4 | 2022 |
